120 related articles for article (PubMed ID: 22849938)
1. [Hepatitis C in drug addicts: access and treatment compliance].
Sarmento E Castro R; Valente C; Ramos JP; Almeida JR; Marinho RT; Branco T; Andrade S; Macedo A
Acta Med Port; 2011 Dec; 24 Suppl 2():483-92. PubMed ID: 22849938
[TBL] [Abstract][Full Text] [Related]
2. Treatment of chronic hepatitis C in active drug users.
Davis GL; Rodrigue JR
N Engl J Med; 2001 Jul; 345(3):215-7. PubMed ID: 11463020
[No Abstract] [Full Text] [Related]
3. Guidelines for the treatment of hepatitis C virus infection in injection drug users: status quo in the European Union countries.
Reimer J; Schulte B; Castells X; Schafer I; Polywka S; Hedrich D; Wiessing L; Haasen C; Backmund M; Krausz M
Clin Infect Dis; 2005 Apr; 40 Suppl 5():S373-8. PubMed ID: 15768351
[TBL] [Abstract][Full Text] [Related]
4. Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.
Birkhead GS; Klein SJ; Candelas AR; O'Connell DA; Rothman JR; Feldman IS; Tsui DS; Cotroneo RA; Flanigan CA
Int J Drug Policy; 2007 Oct; 18(5):417-25. PubMed ID: 17854731
[TBL] [Abstract][Full Text] [Related]
5. Epidemiological survey of hepatitis C virus infection in a cohort of patients from a ser.T in naples, Italy.
Curcio F; Villano G; Masucci S; Plenzik M; Veneruso C; De Rosa G
J Addict Med; 2011 Mar; 5(1):43-9. PubMed ID: 21769046
[TBL] [Abstract][Full Text] [Related]
6. Treatment for hepatitis C virus infection among current injection drug users in Australia.
Matthews G; Kronborg IJ; Dore GJ
Clin Infect Dis; 2005 Apr; 40 Suppl 5():S325-9. PubMed ID: 15768342
[TBL] [Abstract][Full Text] [Related]
7. Recommendations for the prevention, diagnosis, and treatment of chronic hepatitis B and C in special population groups (migrants, intravenous drug users and prison inmates).
Almasio PL; Babudieri S; Barbarini G; Brunetto M; Conte D; Dentico P; Gaeta GB; Leonardi C; Levrero M; Mazzotta F; Morrone A; Nosotti L; Prati D; Rapicetta M; Sagnelli E; Scotto G; Starnini G
Dig Liver Dis; 2011 Aug; 43(8):589-95. PubMed ID: 21256097
[TBL] [Abstract][Full Text] [Related]
8. Management and treatment of injection drug users with hepatitis C virus (HCV) infection and HCV/human immunodeficiency virus coinfection.
Dore GJ; Thomas DL
Semin Liver Dis; 2005 Feb; 25(1):18-32. PubMed ID: 15731995
[TBL] [Abstract][Full Text] [Related]
9. [Prevention and treatment of hepatitis C in illicit drug users].
Sakoman S
Acta Med Croatica; 2009 Dec; 63(5):437-42. PubMed ID: 20198904
[TBL] [Abstract][Full Text] [Related]
10. Antiviral treatment for chronic hepatitis C in illicit drug users: a systematic review.
Zanini B; Lanzini A
Antivir Ther; 2009; 14(4):467-79. PubMed ID: 19578232
[TBL] [Abstract][Full Text] [Related]
11. Clinical management of drug addicts infected with human immunodeficiency virus and hepatitis C virus.
Khalsa JH; Vocci F
J Addict Dis; 2008; 27(2):1-10. PubMed ID: 18681186
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness and tolerability of combination treatment of chronic hepatitis C in illicit drug users: meta-analysis of prospective studies.
Zanini B; Covolo L; Donato F; Lanzini A
Clin Ther; 2010 Dec; 32(13):2139-59. PubMed ID: 21316533
[TBL] [Abstract][Full Text] [Related]
13. Differences in access to care among injection drug users infected either with HIV and hepatitis C or hepatitis C alone.
Braitstein P; Li K; Kerr T; Montaner JS; Hogg RS; Wood E
AIDS Care; 2006 Oct; 18(7):690-3. PubMed ID: 16971276
[TBL] [Abstract][Full Text] [Related]
14. Health-related quality of life in active injecting drug users with and without chronic hepatitis C virus infection.
Dalgard O; Egeland A; Skaug K; Vilimas K; Steen T
Hepatology; 2004 Jan; 39(1):74-80. PubMed ID: 14752825
[TBL] [Abstract][Full Text] [Related]
15. [Prevalence of chronic viral hepatitis in drug abusers].
Osztrogonácz H; Gerevich J; Horváth G; Tolvaj G; Dávid K
Orv Hetil; 2000 Apr; 141(14):715-8. PubMed ID: 10803013
[TBL] [Abstract][Full Text] [Related]
16. HIV/hepatitis coinfection in eastern Europe and new pan-European approaches to hepatitis prevention and management.
Lazarus JV; Shete PB; Eramova I; Merkinaite S; Matic S
Int J Drug Policy; 2007 Oct; 18(5):426-32. PubMed ID: 17854732
[TBL] [Abstract][Full Text] [Related]
17. Treatment of chronic hepatitis C in patients with drug dependence: time to change the rules?
Schaefer M; Heinz A; Backmund M
Addiction; 2004 Sep; 99(9):1167-75. PubMed ID: 15317637
[TBL] [Abstract][Full Text] [Related]
18. Medical management of HIV-hepatitis C virus coinfection in injection drug users.
Khalsa JH; Kresina T; Sherman K; Vocci F
Clin Infect Dis; 2005 Jul; 41 Suppl 1():S1-6. PubMed ID: 16265605
[TBL] [Abstract][Full Text] [Related]
19. Follow-up studies of treatment for hepatitis C virus infection among injection drug users.
Dalgard O
Clin Infect Dis; 2005 Apr; 40 Suppl 5():S336-8. PubMed ID: 15768344
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of hepatitis C in intravenous drug users].
Filoche B
Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B252-6. PubMed ID: 12180298
[No Abstract] [Full Text] [Related]
[Next] [New Search]
